×
Further changes are likely after the publication of the final Cass report expected in April 2024. Puberty blockers (PB) as a treatment for gender dysphoria will no longer be prescribed by NHS England providers as of April 1, 2024.
Mar 29, 2024
People also ask
Puberty blockers (gonadotrophin-releasing hormone analogues) are not available to children and young people for gender incongruence or gender dysphoria because ...
The policy proposition is that puberty suppressing hormones are not recommended to be available as a routine commissioning option for the treatment of children ...
Mar 14, 2024 · Maria Caulfield, health minister, said, “We welcome this landmark decision by the NHS to end the routine prescription of puberty blockers and ...
Mar 19, 2024 · Starting April 1, NHS England will not prescribe puberty blockers — drugs that suppress sex hormones during puberty — as a “routine ...
Mar 12, 2024 · Children will no longer routinely be prescribed puberty blockers at gender identity clinics, NHS England has confirmed.
publishing, following full public consultation and engagement, a new evidence based clinical policy on puberty supressing hormones (also called puberty blockers) ...
Mar 13, 2024 · England's National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or ...
Mar 13, 2024 · The NHS has not stated it will restrict puberty blockers for non-transgender children and young people.
Mar 12, 2024 · Children who have gender dysphoria will no longer be given puberty blockers, NHS England has said, ahead of a radical change in how it cares for ...